Biopharmaceutical Company Achieves Major Milestone Towards Tropical Disease Treatment

PaxMedica Achieves Key Milestone in PAX-101 Development: A Leap Towards Revolutionary Treatment for Neglected Tropical Disease.

Disclaimer: All information provided is based on the latest available data and aims to be accurate and factual. No promotional intent is intended to undermine the integrity of any organization or individual.